India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

 

Issue dated - 19th Aug. 2004

Home > Policy > Story Printer Friendly Page|  Email this page

NPPA notifies norms for CC, PC and PL

EPP News Bureau - New Delhi

The National Pharmaceutical Pricing Authority (NPPA) has notified the norms for conversion cost (CC), packing charges (PC) and process loss (PL) of materials vide S O No. 913 (E) dated 11.08.2004, in pursuance of para 7 of the Drugs (Prices Control) Order,1995 read with S O 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilisers.

These norms have been notified based on a comprehensive study carried out by the Cost Account Branch of Ministry of Finance. While finalising the study, the Cost Account Branch has applied established procedures and principles of costing. Norms have been prescribed for certain category of items for the first time.

The norms for conversion costs and packing charges by and large have increased over the existing ones while the norms for process loss of materials have come down for all category of items.

The National Pharmaceutical Pricing Authority has fixed/revised the prices in respect of 11 formulation packs, imported in finished form on 11h August, 2004 based on the bulk drug insulin and methyl prednisolone sodium succinate on the basis of applications received from Novo Nordisk and Pharmacia Ltd respectively. These prices have been fixed/revised in accordance with the provisions of the Drugs (Prices Control) Order (DPCO), 1995 and as per the established criteria and guidelines. The prices fixed/revised would become effective within 15 days from the date of notification in the official gazette or the receipt of the Non-ceiling, price (NCP) Order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995.

Necessary revised price list is to be issued by the manufacturers/importers required under sub-paragraph (3) of paragraph 14 of the DPCO, 1995. Accordingly, as per provision, the revised price list in Form-V of the DPCO is to be furnished by the concerned manufacturer(s) to the government and NPPA, state drug control authorities and distributors, wholesalers and retailers or any other agent.

INSIDE PHARMA
EDITORIAL
OPED
CORPORATE
MARKET PLACE
CONTRACT RESEARCH
NEWS & VIEWS
PHARMA TOON
DISEASE
HAPPENINGS
POLICY
REGULATORY
BOOK REVIEW
PRODUCTS
Pharma Research
(Adobe PDF file)
[an error occurred while processing this directive]


Advanced Search
ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express
<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.